Loading clinical trials...
Loading clinical trials...
Multi-Center, Randomized, Double-Blind Active-Controlled, Parallel Group Study to Investigate Plasma Folate, Red Blood Cell Folate and Homocysteine Levels During a 24 Week Oral Administration of an OC Containing Folate Compared to OC Alone
The purpose of this study is to determine whether the study drug is safe and effective
Acronym is used in result section: suspected/diagnosed (susp/diag)
Age
18 - 40 years
Sex
FEMALE
Healthy Volunteers
Yes
Orange County Clinical Trials
Anaheim, California, United States
Medical Center for Clinical Research
San Diego, California, United States
SNBL Clinical Pharmacology Center, Inc.
Baltimore, Maryland, United States
Columbia University Medical Center
New York, New York, United States
AAIPharma, Inc.
Morrisville, North Carolina, United States
Lyndhurst Gynecologic Associates
Winston-Salem, North Carolina, United States
Coastal Carolina Research Center
Mt. Pleasant, South Carolina, United States
New Orleans Center for Clinical Research
Knoxville, Tennessee, United States
NorthWest Kinetics
Tacoma, Washington, United States
Start Date
April 1, 2007
Primary Completion Date
August 1, 2008
Completion Date
September 1, 2008
Last Updated
April 23, 2014
385
ACTUAL participants
Drospirenone/Ethinylestradiol/Methyltetrahydrofolate
DRUG
Drospirenone/Ethinylestradiol (Yaz)
DRUG
Lead Sponsor
Bayer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06672016